Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38234
CAS Number:
145202-66-0
Rizatriptan benzoate
Purity:
≥ 98% (Assay by titration, HPLC)
Synonym(s):
N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylaminebenzoate
Documents
$310.97 /50MG
Pack Size Availability Price
Request Bulk Quote
Product Information

Rizatriptan benzoate is a potent pharmaceutical compound primarily used in the treatment of acute migraine attacks. As a selective serotonin receptor agonist, it effectively alleviates migraine symptoms by constricting dilated blood vessels in the brain and reducing inflammation. This compound is particularly valued for its rapid onset of action, making it a preferred choice for patients seeking immediate relief from debilitating migraine episodes. Its unique formulation allows for oral administration, providing convenience and ease of use for patients.

In addition to its primary application in migraine therapy, Rizatriptan benzoate has shown potential in research settings for exploring new therapeutic avenues in headache disorders. Its efficacy and safety profile make it a subject of interest for further studies aimed at understanding its broader implications in neurology. With its targeted action and favorable pharmacokinetics, Rizatriptan benzoate stands out as a reliable option for both healthcare professionals and patients in managing migraine conditions effectively.

Synonyms
N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylaminebenzoate
CAS Number
145202-66-0
Purity
≥ 98% (Assay by titration, HPLC)
Molecular Formula
C15H19N5·C7H6O2
Molecular Weight
391.48
MDL Number
MFCD00866224
PubChem ID
77997
Melting Point
178 - 182 °C
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
General Information
Synonyms
N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylaminebenzoate
CAS Number
145202-66-0
Purity
≥ 98% (Assay by titration, HPLC)
Molecular Formula
C15H19N5·C7H6O2
Molecular Weight
391.48
MDL Number
MFCD00866224
PubChem ID
77997
Melting Point
178 - 182 °C
Appearance
White to almost white powder to crystal
Conditions
Store at 2 - 8 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Rizatriptan benzoate is widely utilized in research focused on

  • Migraine Treatment: This compound is primarily used in the pharmaceutical industry for the acute treatment of migraines, providing rapid relief to patients by targeting serotonin receptors in the brain.
  • Clinical Trials: It plays a significant role in clinical research, helping to evaluate the efficacy and safety of new formulations or combinations with other medications aimed at headache disorders.
  • Pharmacokinetic Studies: Researchers utilize it to study the absorption, distribution, metabolism, and excretion (ADME) properties, which are crucial for developing effective dosing regimens.
  • Formulation Development: The compound is involved in the development of various dosage forms, including tablets and orally disintegrating formulations, enhancing patient compliance and convenience.
  • Comparative Effectiveness Research: It is used in studies comparing the effectiveness of different migraine treatments, helping healthcare providers make informed decisions about patient care.

Citations